Document is current
Any future updates will be listed below
-
Authors
Steinicke, Til L. https://orcid.org/0009-0007-0287-0076
Benfatto, Salvatore https://orcid.org/0000-0003-4439-3136
Capilla-Guerra, Maria R. https://orcid.org/0009-0005-1199-4295
Monteleone, Andre B. https://orcid.org/0009-0006-9181-1467
Young, Jonathan H. https://orcid.org/0000-0003-3365-2702
Shankar, Subha
Michaels, Phillip D.
Tsai, Harrison K.
Good, Jonathan D.
Kreso, Antonia
van Galen, Peter https://orcid.org/0000-0002-0735-1570
Schliemann, Christoph https://orcid.org/0000-0003-1755-9583
Chen, Evan C.
Griffin, Gabriel K. https://orcid.org/0000-0002-4042-6757
Hovestadt, Volker https://orcid.org/0000-0002-3480-6649
- License Information
-
More Information
Article History
Received: 5 November 2024
Accepted: 30 July 2025
First Online: 22 September 2025
Competing interests
: C.S. discloses advisory honoraria from AbbVie, Astellas, AstraZeneca, BMS, Laboratories Delbert, Jazz Pharmaceuticals, Novartis, Otsuka, Pfizer and Roche, institutional research support from Jazz Pharmaceuticals and travel grants from AbbVie, BMS, Jazz Pharmaceuticals and Pfizer. E.C.C. discloses advisory honoraria from AbbVie, Merck, ImCheck, Rigel, Guidepoint, Trinity Health Sciences and GLG, and research support from AbbVie. G.K.G. receives research support from Calico Life Sciences. The other authors declare no competing interests.
